Activation of Microglial Cells: the Bridge between the Immune System and Pain in Central Nervous System by Dabbagh, Ali





Activation of Microglial Cells: the Bridge between the Immune 




After neural cells and oligodendrocytes, microglial 
cells are the 3rd well known cell population in brain 
and spinal cord; though their population "outnumber 
neurons in the central nervous system" (1).  
Recent studies have shown the role of microglial 
cells in development of pain; especially, the 
differences between age and gender groups have been 
claimed to be related to microglial activity in 
neuropathic pain (1). The role of microglial cells is 
proposed to challenge with antigens crossing the blood 
brain barrier or blood nerve barrier and prevent their 
effects in the central nervous system. Microglial cells 
function as macrophages; however, as other tissue-
resident macrophages, microglial cells are descendants 
of yolk-sac-derived erythro-myeloid progenitors; this 
may explain why chronic pain is not a matter of 
concern in neonates (1, 2). 
In this issue of the Journal, Nasseri et al have 
described their findings regarding the role of 
microglial cells in arthritic pain. They have found that 
during different stages of Complete Freund’s adjuvant 
(CFA)-induced inflammation, activation of microglial 
cells plays significant roles in aggravation of pain 
related behaviors; also, the occurring inflammatory 
symptoms would alleviate with steady injection of 
minocycline which is an inhibitor of microglial cells 
(3).  
Though the role of microglial cells and also, the 
inhibitory role of minocycline on microglial cells has 
been described earlier in some studies, the study 
published by Nasseri et al demonstrates both the role 
of spinal microglia activity in induction of pain 
behavioral symptoms and also, the relief of pain related 
behavior after minocycline administration. These 
findings could help us open newer windows towards 
treatment of arthritic pain. For example, Matsumura et 
al demonstrated that intrathecal administration of NP-
1815-PX (a selective antagonist of P2X4R) could 
produce anti-allodynic effects (4, 5); in turn, on the 
surface of microglial cells, expression of P2X4 
receptors is regulated at post‐translational level (6). We 
also know that adenosine triphosphate (ATP)-gated 
cation channel P2X receptors located on microglial 
cells are highly involved in CNS pain mechanisms and 
their antagonism is a potential role in future of clinical 
pain control (5, 7-9). 
The findings of Nasseri et al once again 
demonstrated us that treatment opf pain is in evolution. 
Though this pathway has not reached its final 
destination, alternate drugs except for opioids are 
going to emerge with less unwanted drug effects and 
more targeted pharmacologic effects. The future of 
pain control seems to emerge from bench-to-bedside 
studies, demonstrating another feature of translational 
medicine. 
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